Clearmind Medicine
CMND
4 hedge funds and large institutions have $288K invested in Clearmind Medicine in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
7.23% less ownership
Funds ownership: 13.82% → 6.59% (-7.2%)
33% less funds holding
Funds holding: 6 → 4 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
95% less capital invested
Capital invested by funds: $5.51M → $288K (-$5.22M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$29.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26.1K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$19.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gotham Asset Management
New York
|
-$5.3M |
| 2 |
CWG
Cornerstone Wealth Group
Huntersville,
North Carolina
|
-$18K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$10.2K |
| 4 |
JP Morgan Chase
New York
|
-$3.12K |
CMND Hedge Fund Activity: Q3 2025 in Review
4 of the 7,646 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q3 2025, worth a combined $288K — down 95% from $5.51M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CMND and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $29.3K. The largest seller was Gotham Asset Management, exiting entirely with an estimated $5.3M sold.
- 4 institutional investors held Clearmind Medicine (CMND) as of Q3 2025, down from 6 in Q2 2025.
- Funds reported $288K of Clearmind Medicine stock for Q3 2025, down 95% quarter-over-quarter.
- 2 funds opened new Clearmind Medicine positions in Q3 2025 and 4 closed out, a net change of -2 holders.
- The largest Clearmind Medicine buyer in Q3 2025 was Virtu Financial, an estimated $29.3K added.
- The largest Clearmind Medicine seller in Q3 2025 was Gotham Asset Management, an estimated $5.3M sold.
Based on aggregated 13F filings for Q3 2025.